TRIL

Trillium Therapeutics Inc.
TRIL

Overview Fund Activity
Delisted

TRIL was delisted on the 16th of November, 2021.

Back to rankings

26 hedge funds and large institutions have $23.2M invested in Trillium Therapeutics Inc. in 2017 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
26
Holders Change
+4
Holders Change %
+18.18%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
8
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NMC
1
NEA Management Company
Maryland
$4.62M
2
AIC
2
AWM Investment Company
New York
$4.42M
3
CAM
3
Cormorant Asset Management
Massachusetts
$2.64M
4
Janus Henderson Group
4
Janus Henderson Group
United Kingdom
$2.4M
5
TCM
5
Tekla Capital Management
Massachusetts
$1.98M

Top Sellers

1
Franklin Resources
1
Franklin Resources
California
$89K
2
ACA
2
Avoro Capital Advisors
New York
$0
3
IBT
3
International Biotechnology Trust
United Kingdom
$693K
4
ARTA
4
A.R.T. Advisors
New York
$0
5
Millennium Management
5
Millennium Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
ARTA
26
A.R.T. Advisors
New York
– -$143K -23,225 Closed
Millennium Management
27
Millennium Management
New York
– -$62K -10,126 Closed
UBS Group
28
UBS Group
Switzerland
– -$12K -1,997 Closed
Bank of America
29
Bank of America
North Carolina
– -$7K -1,100 Closed
1
2